IBI3004

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBI3004, covering 2025-12-30 to 2025-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI3004 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]